Stuart Essig is Executive Chairman of Integra LifeSciences Holdings Corporation (NASDAQ: IART). He served as the company’s chief executive officer from 1997 to 2012, building Integra into a global surgical products leader. During Stuart’s 26-year tenure with the company, Integra has grown revenues from $15 million to over $1.6 billion and its market capitalization from approximately $100 million to an enterprise valuation of more than $6.0 billion. Stuart serves as managing partner of Prettybrook Partners, LLC. He is a director of IDEXX Laboratories, Inc. (NASDAQ:IDXX), Mission Bio and Availity, LLC. Previously, Stuart served on the boards of Orthofix Medical, Inc. (NASDAQ:OFIX), Seaspine Corporation (NASDAQ:SPNE), St. Jude Medical (NYSE:STJ), Zimmer Biomet Holdings, Inc. (NYSE: ZBH), Owens & Minor, Inc. (NYSE: OMI) and Vital Signs, Inc. (NASDAQ:VITL). He previously was lead director and formerly chairman of the Board of Directors of private equity-backed Breg, Inc. Prior to Integra, Stuart was a managing director in mergers and acquisitions for the Goldman Sachs Group, Inc., specializing in the medical device, pharmaceutical and biotechnology sectors. After earning his undergraduate degree from Princeton University, Stuart earned a master’s in business administration and a Ph.D. in financial economics from the University of Chicago.Stuart is a global executive who has built and managed profitable sales, marketing and general business operations. He developed diverse sets of leaders across multiple corporations. He executed on an effective succession planning process whereby the company he led for fifteen years effectively recruited his successor.Stuart has chaired Audit, Compensation, Finance and Nominating and Governance Committees and served on the boards of several Fortune 500, NASDAQ and NYSE listed companies ranging in size from several hundred million dollars to more than $55 billion in market capitalization. He has served on the Executive committee, Nominating and Governance committee and as Treasurer of ADVAMED, the Advanced Medical Technology Association.